Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease | Zendy

Anna Franzone | Zendy; Raffaele Piccolo | Zendy; Giuseppe Gargiulo | Zendy; Sara Ariotti | Zendy; Marcello Marino | Zendy; Andrea Santucci | Zendy; Andrea Baldo | Zendy; Giulia Magnani | Zendy; Aris Moschovitis | Zendy; Stephan Windecker | Zendy; Marco Valgimigli | Zendy

Open Access

Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease

Author(s) -

Anna Franzone,

Raffaele Piccolo,

Giuseppe Gargiulo,

Sara Ariotti,

Marcello Marino,

Andrea Santucci,

Andrea Baldo,

Giulia Magnani,

Aris Moschovitis,

Stephan Windecker,

Marco Valgimigli

Publication year - 2016

Publication title -

jama cardiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.108

H-Index - 63

eISSN - 2380-6591

pISSN - 2380-6583

DOI - 10.1001/jamacardio.2016.2811

Subject(s) - medicine , percutaneous coronary intervention , conventional pci , myocardial infarction , coronary artery disease , concomitant , cardiology , clinical endpoint , stent , surgery , randomized controlled trial

Patients with concomitant peripheral arterial disease (PAD) experience worse cardiovascular outcomes after percutaneous coronary intervention (PCI).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research